Repeated aripiprazole treatment regulates Bdnf, Arc and Npas4 expression under basal condition as well as after an acute swim stress in the rat brain

Pharmacological Research

Volumn 80, Issue , 2014, Pages 1-8

  Luoni, Alessia ^a   Fumagalli, Fabio ^a   Racagni, Giorgio ^a   Riva, Marco A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Acute swim stress; ARC; Aripiprazole; BDNF; NPAS4

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; ARIPIPRAZOLE; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; ACTIVITY REGULATED CYTOSKELETAL-ASSOCIATED PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CYTOSKELETON PROTEIN; NERVE PROTEIN; NEUROLEPTIC AGENT; NPAS4 PROTEIN, RAT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN GENE; ACUTE STRESS; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; CONTROLLED STUDY; DENDRITE; FORCED SWIM TEST; GENE EXPRESSION; IMMEDIATE EARLY GENE; MALE; NERVE CELL PLASTICITY; NEURONAL PAS DOMAIN PROTEIN 4 GENE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; UPREGULATION; ANIMAL; BIOSYNTHESIS; DRUG ADMINISTRATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGICAL STRESS;

ANIMALS; ANTIPSYCHOTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYTOSKELETAL PROTEINS; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION; MALE; NERVE TISSUE PROTEINS; PIPERAZINES; PREFRONTAL CORTEX; QUINOLONES; RATS; STRESS, PHYSIOLOGICAL;

EID: 84891822144     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.11.008     Document Type: Article

References (54)

1. P.N. McCormick, V.S. Wilson, A.A. Wilson, and G.J. Remington Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors Pharmacol Res 70 2013 66 71
2. H.Y. Meltzer, and T. Sumiyoshi Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia Behav Brain Res 195 2008 98 102
3. H.Y. Meltzer Outcome in schizophrenia: beyond symptom reduction J Clin Psychiatry 60 1999 3 7 discussion 8
4. A. Bortolozzi, L. Diaz-Mataix, M. Toth, P. Celada, and F. Artigas In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain Psychopharmacology (Berl) 191 2007 745 758
5. T.M. Bowles, and G.M. Levin Aripiprazole: a new atypical antipsychotic drug Ann Pharmacother 37 2003 687 694
6. D.A. Shapiro, S. Renock, E. Arrington, L.A. Chiodo, L.X. Liu, and D.R. Sibley et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology Neuropsychopharmacology 28 2003 1400 1411
7. R. Molteni, F. Calabrese, A. Cattaneo, M. Mancini, M. Gennarelli, and G. Racagni et al. Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine Neuropsychopharmacology 34 2009 1523 1532
8. J.A. Lieberman, F.P. Bymaster, H.Y. Meltzer, A.Y. Deutch, G.E. Duncan, and C.E. Marx et al. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection Pharmacol Rev 60 2008 358 403
9. R.W. Grillo, G.L. Ottoni, R. Leke, D.O. Souza, L.V. Portela, and D.R. Lara Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics J Psychiatr Res 41 2007 31 35
10. M.H. Xiu, L. Hui, Y.F. Dang, T.D. Hou, C.X. Zhang, and Y.L. Zheng et al. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics Prog Neuropsychopharmacol Biol Psychiatry 33 2009 1508 1512
11. M. Thompson Ray, C.S. Weickert, E. Wyatt, and M.J. Webster Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders J Psychiatry Neurosci 36 2011 195 203
12. C.S. Weickert, T.M. Hyde, B.K. Lipska, M.M. Herman, D.R. Weinberger, and J.E. Kleinman Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia Mol Psychiatry 8 2003 592 610
13. F. Fumagalli, F. Bedogni, J. Perez, G. Racagni, and M.A. Riva Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress Eur J Neurosci 20 2004 1348 1354
14. M. Roceri, W. Hendriks, G. Racagni, B.A. Ellenbroek, and M.A. Riva Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus Mol Psychiatry 7 2002 609 616
15. M. Roceri, F. Cirulli, C. Pessina, P. Peretto, G. Racagni, and M.A. Riva Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions Biol Psychiatry 55 2004 708 714
16. F. Angelucci, A.A. Mathe, and L. Aloe Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration J Neurosci Res 60 2000 783 794
17. O. Bai, J. Chlan-Fourney, R. Bowen, D. Keegan, and X.M. Li Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs J Neurosci Res 71 2003 127 131
18. A. Pillai, A.V. Terry Jr., and S.P. Mahadik Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus Schizophr Res 82 2006 95 106
19. F. Fumagalli, F. Calabrese, A. Luoni, F. Bolis, G. Racagni, and M.A. Riva Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress Int J Neuropsychopharmacol 15 2012 235 246
20. J.J. An, K. Gharami, G.Y. Liao, N.H. Woo, A.G. Lau, and F. Vanevski et al. Distinct role of long 3′ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons Cell 134 2008 175 187
21. G. Baj, E. Leone, M.V. Chao, and E. Tongiorgi Spatial segregation of BDNF transcripts enables BDNF to differentially shape distinct dendritic compartments Proc Natl Acad Sci U S A 108 2011 16813 16818
22. F. Fumagalli, F. Calabrese, A. Luoni, M. Shahid, G. Racagni, and M.A. Riva The AMPA receptor potentiator Org 26576 modulates stress-induced transcription of BDNF isoforms in rat hippocampus Pharmacol Res 65 2012 176 181
23. S. Chourbaji, C. Brandwein, M.A. Vogt, C. Dormann, R. Hellweg, and P. Gass Nature vs. nurture: can enrichment rescue the behavioural phenotype of BDNF heterozygous mice? Behav Brain Res 192 2008 254 258
24. S. Chourbaji, H. Hortnagl, R. Molteni, M.A. Riva, P. Gass, and R. Hellweg The impact of environmental enrichment on sex-specific neurochemical circuitries - effects on brain-derived neurotrophic factor and the serotonergic system Neuroscience 220 2012 267 276
25. S. Chourbaji, C. Brandwein, and P. Gass Altering BDNF expression by genetics and/or environment: impact for emotional and depression-like behaviour in laboratory mice Neurosci Biobehav Rev 35 2011 599 611
26. F. Calabrese, R. Molteni, P.F. Maj, A. Cattaneo, M. Gennarelli, and G. Racagni et al. Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein Neuropsychopharmacology 32 2007 2351 2359
27. G. Paxinos, and C. Watson The rat brain in stereotaxis coordinates 1996 Academic Press New York
28. C.R. Bramham, P.F. Worley, M.J. Moore, and J.F. Guzowski The immediate early gene arc/arg3.1: regulation, mechanisms, and function J Neurosci 28 2008 11760 11767
29. Y. Lin, B.L. Bloodgood, J.L. Hauser, A.D. Lapan, A.C. Koon, and T.K. Kim et al. Activity-dependent regulation of inhibitory synapse development by Npas4 Nature 455 2008 1198 1204
30. J.F. Maya-Vetencourt Activity-dependent expression and the regulation of gene programs underlying plasticity in the central nervous system Neural Plast 2013 2013 683909
31. P. Pruunsild, M. Sepp, E. Orav, I. Koppel, and T. Timmusk Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene J Neurosci 31 2011 3295 3308
32. G. Guidotti, F. Calabrese, F. Auletta, J. Olivier, G. Racagni, and J. Homberg et al. Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment Neuropsychopharmacology 37 2012 746 758
33. A.G. Lau, H.A. Irier, J. Gu, D. Tian, L. Ku, and G. Liu et al. Distinct 3′ UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF) Proc Natl Acad Sci U S A 107 2010 15945 15950
34. L.L. Orefice, E.G. Waterhouse, J.G. Partridge, R.R. Lalchandani, S. Vicini, and B. Xu Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines J Neurosci 33 2013 11618 11632
35. I.M. Ethell, and E.B. Pasquale Molecular mechanisms of dendritic spine development and remodeling Prog Neurobiol 75 2005 161 205
36. C. Chiaruttini, M. Sonego, G. Baj, M. Simonato, and E. Tongiorgi BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae Mol Cell Neurosci 37 2008 11 19
37. J. van Os, and J.P. Selten Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands Br J Psychiatry 172 1998 324 326
38. R. Molteni, F. Calabrese, S. Chourbaji, C. Brandwein, G. Racagni, and P. Gass et al. Depression-prone mice with reduced glucocorticoid receptor expression display an altered stress-dependent regulation of brain-derived neurotrophic factor and activity-regulated cytoskeleton-associated protein J Psychopharmacol 24 2010 595 603
39. C.M. Pariante, A. Makoff, S. Lovestone, S. Feroli, A. Heyden, and A.H. Miller et al. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters Br J Pharmacol 134 2001 1335 1343
40. A.O.M. Bennett Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression Aust N Z J Psychiatry 42 2008 995 1002
41. D. Cotter, and C.M. Pariante Stress and the progression of the developmental hypothesis of schizophrenia Br J Psychiatry 181 2002 363 365
42. K. Van Craenenbroeck, K. De Bosscher, W. Vanden Berghe, P. Vanhoenacker, and G. Haegeman Role of glucocorticoids in dopamine-related neuropsychiatric disorders Mol Cell Endocrinol 245 2005 10 22
43. J. Chlan-Fourney, P. Ashe, K. Nylen, A.V. Juorio, and X.M. Li Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration Brain Res 954 2002 11 20
44. F. Fumagalli, R. Molteni, M. Roceri, F. Bedogni, R. Santero, and C. Fossati et al. Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity J Neurosci Res 72 2003 622 628
45. S.W. Park, C.H. Lee, J.G. Lee, S.J. Lee, N.R. Kim, and S.M. Choi et al. Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats J Psychiatr Res 43 2009 274 281
46. H. Xu, H. Qing, W. Lu, D. Keegan, J.S. Richardson, and J. Chlan-Fourney et al. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus Neurosci Lett 321 2002 65 68
47. S.W. Park, V.T. Phuong, C.H. Lee, J.G. Lee, M.K. Seo, and H.Y. Cho et al. Effects of antipsychotic drugs on BDNF, GSK-3beta, and beta-catenin expression in rats subjected to immobilization stress Neurosci Res 71 2011 335 340
48. R. Molteni, F. Calabrese, G. Racagni, F. Fumagalli, and M.A. Riva Antipsychotic drug actions on gene modulation and signaling mechanisms Pharmacol Ther 124 2009 74 85
49. F. Fumagalli, A. Frasca, G. Racagni, and M.A. Riva Antipsychotic drugs modulate Arc expression in the rat brain Eur Neuropsychopharmacol 19 2009 109 115
50. L.A. Bruins Slot, F. Lestienne, C. Grevoz-Barret, A. Newman-Tancredi, and D. Cussac F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum Eur J Pharmacol 620 2009 27 35
51. D. Wirtshafter, and A.C. Sheppard Role of dopamine D2 receptors in the striatal immediate early gene response to amphetamine in reserpinized rats Brain Res Bull 62 2003 77 83
52. F. Fumagalli, F. Bedogni, A. Frasca, L. Di Pasquale, G. Racagni, and M.A. Riva Corticostriatal up-regulation of activity-regulated cytoskeletal- associated protein expression after repeated exposure to cocaine Mol Pharmacol 70 2006 1726 1734
53. S. Inoue, M. Susukida, K. Ikeda, K. Murase, and K. Hayashi Dopaminergic transmitter up-regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) synthesis in mouse astrocytes in culture Biochem Biophys Res Commun 238 1997 468 472
54. S.L. Castro, and M.J. Zigmond Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-d-aspartate receptors in substantia nigra Brain Res 901 2001 47 54